journal article·2024-05Open access

Platelet Membrane‐Derived Nanodiscs for Neutralization of Endogenous Autoantibodies and Exogenous Virulence Factors

Lei Sun, Yiyan Yu, Yifei Peng, Dan Wang, Shuyan Wang, Ilkoo Noh, Ronnie H. Fang, Weiwei Gao, Liangfang Zhang

Small· Volume 20· Issue 18

Abstract

Abstract The multifaceted functions of platelets in various physiological processes have long inspired the development of therapeutic nanoparticles that mimic specific platelet features for disease treatment. Here, the development and characterization of platelet membrane‐derived nanodiscs (PLT‐NDs) as platelet decoys for biological neutralization is reported. In one application, PLT‐NDs effectively bind with anti‐platelet autoantibodies, thus blocking them from interacting with platelets. In a mouse model of thrombocytopenia, PLT‐NDs successfully neutralize pathological anti‐platelet antibodies, preventing platelet depletion and maintaining hemostasis. In another application, PLT‐NDs effectively neutralize the cytotoxicity of bacterial virulence factors secreted by methicillin‐resistant Staphylococcus aureus (MRSA). In a mouse model of MRSA infection, treatment with PLT‐NDs leads to significant survival benefits for the infected mice. Additionally, PLT‐NDs show good biocompatibility and biosafety, as demonstrated in acute toxicity studies conducted in mice. These findings underscore the potential of PLT‐NDs as a promising platelet mimicry for neutralizing various biological agents that target platelets. Overall, this work expands the repertoire of platelet‐mimicking nanomedicine by creating a unique disc‐like nanostructure made of natural platelet membranes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Platelet Disorders and Treatments · Drug-Induced Adverse Reactions · Blood groups and transfusion

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of NanoEngineering Chemical Engineering Program Shu and K.C. Chien and Peter Farrell Collaboratory University of California San Diego La Jolla CA 92093 USA

Funding

Defense Threat Reduction Agency

References (36)

Show source-provided references
1. 10.1182/blood-2017-06-74267610.1182/blood-2017-06-742676 ↗
2. 10.1038/nri295610.1038/nri2956 ↗
3. 10.3389/fimmu.2015.0008210.3389/fimmu.2015.00082 ↗
4. 10.1007/s11705-017-1614-610.1007/s11705-017-1614-6 ↗
5. 10.1021/acsmaterialslett.2c0083210.1021/acsmaterialslett.2c00832 ↗
6. 10.1002/adma.20150332310.1002/adma.201503323 ↗
7. 10.1021/nn503732m10.1021/nn503732m ↗
8. 10.1002/smll.20140153010.1002/smll.201401530 ↗
9. 10.1038/nature1537310.1038/nature15373 ↗
10. 10.1002/sstr.20200001810.1002/sstr.202000018 ↗
11. 10.1126/sciadv.aaz610810.1126/sciadv.aaz6108 ↗
12. Zhou Y. · Adv. Mater. · 2023 · 35
13. 10.1002/adma.20190514510.1002/adma.201905145 ↗
14. 10.1126/scitranslmed.abb897510.1126/scitranslmed.abb8975 ↗
15. Roullet S. · Blood · 2023 · 141 · 2891
16. 10.1021/acsnano.2c0530610.1021/acsnano.2c05306 ↗
17. 10.1021/acsnano.2c0836010.1021/acsnano.2c08360 ↗
18. Sun L. · Angew. Chem., Int. Ed. · 2023 · 62
19. 10.1016/j.febslet.2009.10.02410.1016/j.febslet.2009.10.024 ↗
20. 10.1038/nsmb.319510.1038/nsmb.3195 ↗
21. 10.1038/nmat482210.1038/nmat4822 ↗
22. 10.1002/adma.20120060710.1002/adma.201200607 ↗
23. 10.3390/cells1012338610.3390/cells10123386 ↗
24. 10.3389/fimmu.2018.0088010.3389/fimmu.2018.00880 ↗
25. 10.1016/j.tim.2008.05.00210.1016/j.tim.2008.05.002 ↗
26. 10.3390/toxins1310067710.3390/toxins13100677 ↗
27. 10.1021/acsnano.6b0485810.1021/acsnano.6b04858 ↗
28. 10.1182/blood.V96.8.283410.1182/blood.V96.8.2834 ↗
29. 10.1016/j.biomaterials.2016.10.00310.1016/j.biomaterials.2016.10.003 ↗
30. 10.1182/blood-2012-10-46145910.1182/blood-2012-10-461459 ↗
31. 10.1111/j.1462-5822.2012.01832.x10.1111/j.1462-5822.2012.01832.x ↗
32. 10.1038/s41598-018-34473-w10.1038/s41598-018-34473-w ↗
33. 10.1016/j.eng.2020.09.01310.1016/j.eng.2020.09.013 ↗
34. 10.1002/adma.20210292610.1002/adma.202102926 ↗
35. 10.3390/antiox1002031310.3390/antiox10020313 ↗
36. 10.3390/metabo1011042910.3390/metabo10110429 ↗